Device type · CGN
Acid, Folic, Radioimmunoassay
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
CGN
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
5
510(k), De Novo and PMA
Adverse event reports
14
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Acid, Folic, Radioimmunoassay
- Product code
- CGN
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1295
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CGN
Latest FDA decisions
- Elecsys Folate III510(k)
K233060 · Decided Jun 17, 2024 · 266 days after receipt
Device type: Acid, Folic, Radioimmunoassay (CGN) · Laboratory Medicine & Pathology
- Access Folate Assay510(k)
K223590 · Decided Aug 23, 2023 · 265 days after receipt
Device type: Acid, Folic, Radioimmunoassay (CGN) · Laboratory Medicine & Pathology
- LIAISON® Folate510(k)
K192586 · Decided May 6, 2020 · 230 days after receipt
Device type: Acid, Folic, Radioimmunoassay (CGN) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Reports received
14
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
14
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 2 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 3 | 0 | 0 | 0 |
| Jul 24 | 1 | 0 | 0 | 0 |
| Aug 24 | 3 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 3 | 0 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 3 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 3 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 1 | 0 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 1 | 0 | 0 | 0 |
| Aug 26 | 2 | 0 | 0 | 0 |
| Sep 26 | 3 | 0 | 0 | 0 |
| Oct 26 | 3 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Low Test Results5
- High Test Results4
- Non Reproducible Results3
5 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions14
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- VITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2Open, Classified
Ortho-Clinical Diagnostics, Inc.
Z-2580-2024 · Started Jul 3, 2024 · Posted by FDA Aug 12, 2024
Reason given: It was confirmed that fibrinogen in patient plasma samples precipitates out of solution upon the addition of folate stabilizer reagent as part of the pre-treatment process causing the increase in "TM5-4MB" condition codes which lead to a delay of results.
Cause as FDA categorized it: Software Design Change
Siemens Healthcare Diagnostics, Inc.
Z-1149-2023 · Started Jan 9, 2023 · Posted by FDA Feb 21, 2023
Reason given: Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.
Cause as FDA categorized it: Under Investigation by firm
Siemens Healthcare Diagnostics, Inc.
Z-1150-2023 · Started Jan 9, 2023 · Posted by FDA Feb 21, 2023
Reason given: Negative bias occurred when whole blood calibration (Atellica IM Fol or ADVIA Centaur FolateBA/FolBA) used to test serum samples.
Cause as FDA categorized it: Under Investigation by firm
25 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.